Description
This issue comprises two parts. The first part examines pharmacology of drug classes and effects on the slee–wake processes. The second part focuses on therapeutics for various sleep disorders. In the first part, basic neuropharmacology of sleep-wake states is discussed. Other articles review hypnotics, allergy and cardiovascular drugs, anti-convulsant drugs, anti-depressant and anti-psychotic drugs, and stimulants. The second part focuses on pharmacology for specific sleep disorders: primary insomnia, co-morbid insomnia, sleep-related breathing disorders, narcolepsy and disorders of daytime sleepiness, movement disroders, parasomnias, and circadian rhythm disorders.
